Last reviewed: July 17, 2026
Last updated: July 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide, marketed as Mounjaro, arrives as a prefilled pen injection administered subcutaneously once each week. Unlike some GLP-1 therapies, tirzepatide has no FDA-approved oral formulation on the market. PlexusDx provides compounded versions in both injectable and oral formats, allowing patients to select the delivery method that fits their lifestyle and treatment goals.
What Form Does Mounjaro Come In?
Mounjaro is a GLP-1 receptor agonist and GIP receptor agonist dual-action medication available exclusively as a subcutaneous injection. The medication comes in a disposable, prefilled pen that patients use to inject themselves once weekly into the abdomen, thigh, or upper arm. Each pen contains a fixed dose of tirzepatide, with strength options ranging from 2.5 mg to 15 mg per injection. The injectable format ensures consistent drug absorption and reliable blood concentration levels throughout the week.
The prefilled pen design removes the need for patients to mix or measure medication, reducing preparation time and potential dosing errors. Patients typically rotate injection sites to minimize tissue irritation and lipodystrophy—abnormal fat deposits or loss at injection sites. The needle is thin and short, designed to minimize discomfort during subcutaneous delivery. Most patients report minimal pain and can complete the injection in under 10 seconds.
Why Mounjaro Remains Injectable Only
Tirzepatide's molecular structure and size make oral absorption challenging without special formulation techniques. The peptide hormone breaks down in stomach acid before the body can use it, which is why the injectable route delivers the full therapeutic dose directly into body tissues. Pharmaceutical companies have invested heavily in oral formulations of other GLP-1 medications like semaglutide, but tirzepatide's dual-receptor mechanism creates additional complexity for oral delivery. As of now, no FDA-approved oral tirzepatide exists in the commercial market.
Injectable delivery also provides superior bioavailability—the amount of active drug reaching the bloodstream—compared to swallowing a tablet. Once-weekly dosing from an injection creates steadier hormone levels than multiple daily oral doses might achieve. Patients seeking tirzepatide therapy must commit to the injectable route or explore compounded alternatives that offer different delivery methods.
PlexusDx Compounded Tirzepatide: Oral and Injectable Options
PlexusDx partners with licensed 503A compounding pharmacies to create both injectable and oral tirzepatide formulations tailored to individual patient needs. Compounded tirzepatide injections begin at $289/mo (or $249/mo on the 6-month plan), maintaining the same weekly dosing schedule as brand-name Mounjaro. Oral compounded tirzepatide starts at $279 per month, offering patients who prefer not to inject a viable alternative for the same dual-receptor mechanism. Both versions are prepared by licensed compounders and serve all 50 states without requiring insurance approval.
PlexusDx's compounded preparations allow flexibility in dosing schedules and strengths based on individual response and tolerance. Patients can switch between injectable and oral formats if their preference or circumstances change. The Precision Peptide Genetic Test—a $99 add-on after the first month—identifies individual variations in peptide pathways, helping PlexusDx providers optimize which tirzepatide formulation and dose level matches each patient's unique genetic response.
Comparing Injectable vs. Oral GLP-1 Therapy
Injectable GLP-1 medications like Mounjaro offer rapid onset and consistent blood levels, making them effective for rapid weight loss and blood sugar control. Patients typically see appetite suppression within days of the first dose. Injectable formulas bypass gastrointestinal breakdown, ensuring the full dose reaches target receptors. However, some patients hesitate due to needle anxiety or injection site reactions, though both are generally mild and manageable.
Oral GLP-1 options provide convenience for patients who prefer not to inject, reducing the barrier to consistent adherence. PlexusDx's oral semaglutide starts at $289/mo (or $249/mo on the 6-month plan), delivering GLP-1 receptor stimulation through daily tablets. Oral formulations may require multiple daily doses to maintain steady hormone activity, and absorption can be affected by food or stomach acid. Both injectable and oral routes produce weight loss and metabolic benefits—the choice depends on patient preference, lifestyle, and genetic factors identified through the Precision Peptide Genetic Test.
Getting Started With PlexusDx Tirzepatide or Semaglutide
PlexusDx patients begin by completing a comprehensive medical intake focused on weight history, metabolic markers, and genetic predispositions. A licensed provider reviews the patient profile and recommends either semaglutide or tirzepatide in injectable or oral form based on clinical fit. Pricing is flat monthly—never dose-based—meaning your dose may need to go up, but your price won't. HSA and FSA funds are accepted, making treatment accessible across income levels.
After one month of therapy, patients can add the Precision Peptide Genetic Test to identify variants in key pathways: GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. This 14-pathway, 49-peptide analysis provides 150+ genetic insights, helping providers fine-tune medication selection and dosing for sustained weight loss. No membership fees or insurance requirements apply—PlexusDx delivers to all 50 states with rapid pharmacy fulfillment.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Mounjaro available as an oral tablet?
No, Mounjaro (tirzepatide) is only available as a once-weekly injection from the manufacturer. PlexusDx offers compounded oral tirzepatide starting at $349/mo (or $279/mo on the 6-month plan) as an alternative, alongside injectable tirzepatide at $289 per month from licensed 503A compounding pharmacies.
Why can't you take tirzepatide by mouth?
Tirzepatide is a peptide hormone that breaks down in stomach acid before the body can absorb it, making injection the most effective route for FDA-approved Mounjaro. PlexusDx's licensed compounders use specialized formulations to create an oral version that bypasses this issue, though efficacy may differ from injectable delivery.
Which is better: Mounjaro injection or oral semaglutide?
Mounjaro (tirzepatide) activates two receptors—GLP-1 and GIP—providing dual metabolic benefits, while semaglutide stimulates GLP-1 alone. PlexusDx offers both as compounded options; the best choice depends on individual genetic response, which the Precision Peptide Genetic Test can help identify through analysis of four key variants across 14 pathways.
Do PlexusDx compounded medications work as well as brand-name Mounjaro?
PlexusDx compounded tirzepatide and semaglutide are prepared by licensed 503A compounding pharmacies using USP-grade ingredients and follow the same pharmaceutical standards as commercial versions. Efficacy depends on individual absorption, compliance, and genetic factors—which is why the optional Precision Peptide Genetic Test helps optimize your specific medication match.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to reveal your peptide pathway strengths and weaknesses across 14 metabolic pathways. This $99 add-on test (available after one month of treatment) provides 150+ insights that help PlexusDx providers optimize your tirzepatide or semaglutide dose and delivery method for maximum weight loss and metabolic improvement.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mounjaro Pen Usage: Safety, Troubleshooting, and Why Disassembly is Never Recommended
How Long Do You Take Mounjaro for Effective Weight Management? Your In-Depth Guide